Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis

Current evidence about the association between pioglitazone and bladder cancer risk remains conflict. We aimed to assess the risk of bladder cancer associated with the use of pioglitazone and identify modifiers that affect the results. We systematically searched PubMed, Embase, and Cochrane Central...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Huilin, Shi, Weilong, Fu, Shuangshuang, Wang, Tiansheng, Zhai, Suodi, Song, Yiqing, Han, Jiali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911601/
https://www.ncbi.nlm.nih.gov/pubmed/29476615
http://dx.doi.org/10.1002/cam4.1354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911601/
https://www.ncbi.nlm.nih.gov/pubmed/29476615
http://dx.doi.org/10.1002/cam4.1354

Ejemplares similares